Pomona, California, September 4, 2005 -- Dr. Richard Y. Lee-Founder, President, and CEO of Amsino International, Inc., a California-based manufacturer of disposable medical devices-announced today that effective October 1, 2005, Mr. Jeffrey Huang will join Amsino Medical Group Holdings Co., Ltd. (hereinafter Amsino) to assume the following positions:

* President and Chief Operating Officer, Amsino Medical Group Holdings Co., Ltd.
* President, Amsino Medical Group (HK) Co., Ltd.
* Chairman, Amsino Healthcare (Shanghai) Co., Ltd.
* Chief Operating Officer, Amsino International, Inc.

At Amsino, we believe that Mr. Huang's skills, experience, and personal attributes will facilitate the building of a strong management team, while supporting and driving the growth of the company as a leader in the medical industry in the United States and in the global marketplace.

Mr. Huang has over 24 years of extensive experience in the medical industry and has accumulated a broad range of knowledge in corporate management, manufacturing, financial planning, IPO planning, ERP system implementation, internal audit, investment management, strategic planning, mergers and acquisitions, sales and marketing, and product development - with profound knowledge and understanding of clinical applications of various products ranging from disposable devices, instruments, and durable medical equipment.

Mr. Huang holds a B.S. degree from Fu Jen Catholic University and a MBA degree from Ohio State University specializing in marketing and strategic planning. Following his graduation from Ohio State University, Huang has worked for Panasonic, Eli Lilly, Johnson and Johnson, and he is the founder, president, and COO of Trident Medical Corporation and the CEO of Trident China Operations, chairing various committees including the Finance/IPO Planning Committee and the Strategic Planning Committee.

Mr. Huang will be reporting to Dr. Richard Y. Lee. Huang will head Amsino's Asian Pacific Operations, as well as the daily operations in the United States. His major responsibilities will include, although not limited to the following areas of operation:

* Five-Year Corporate Business Plan and Business Strategy
* Company-wide Organization Structure
* Product Portfolios
* Sales Strategy and Planning R&D Strategy
* Manufacturing Capacity Planning
* Financial Planning/Investment
* HR Planning
* IPO Planning
* Action Plans and Time Table
* Execution and Contingency Plans

When asked about Huang's appointment to Amsino, Dr. Richard Y. Lee responded, "I am confident that Mr. Jeffrey Huang will contribute significantly to Amsino's continued growth and success. I look forward to working with Mr. Jeffrey Huang closely in the years to come in taking Amsino to the next level!"

Amsino is a privately held manufacturing firm that is headquartered in Pomona, California, with manufacturing facilities in Shanghai and Kunshan, China. Amsino employs over 500 people worldwide. Over the past ten years, Amsino has emerged as a leader in healthcare product provision - selling its products in over 30 countries. Amsino offers a wide variety of manufactured healthcare products, such as: Urological Disposables, IV Administration, Enteral Feeding and Irrigation, Respiratory Disposables, General Surgical/Medical, and Patient Care Goods.

# # #

For additional information, please contact Ms. Shirley Hamilton at shirley_hamilton@amsino.com.

BACK TO NEWS